A. E. Watmore

1.8k total citations · 1 hit paper
23 papers, 1.2k citations indexed

About

A. E. Watmore is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, A. E. Watmore has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in A. E. Watmore's work include Acute Myeloid Leukemia Research (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). A. E. Watmore is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). A. E. Watmore collaborates with scholars based in United Kingdom, India and United States. A. E. Watmore's co-authors include A. M. Potter, Curt I. Civin, Frederick G. Behm, R. Becher, J. Michael Andresen, Julian Borrow, Felix Mitelman, Stefano Volinia, Vincent P. Stanton and David E. Housman and has published in prestigious journals such as Nature Genetics, British Journal of Cancer and British Journal of Haematology.

In The Last Decade

A. E. Watmore

23 papers receiving 1.2k citations

Hit Papers

The translocation t(8;16)(p11;p13) of acute myeloid leuka... 1996 2026 2006 2016 1996 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. E. Watmore United Kingdom 14 701 638 359 135 125 23 1.2k
Paul Sinclair United Kingdom 16 306 0.4× 474 0.7× 285 0.8× 137 1.0× 153 1.2× 24 827
Traudl Henn Austria 14 426 0.6× 492 0.8× 303 0.8× 66 0.5× 117 0.9× 21 1.0k
Jastinder Sohal United Kingdom 11 408 0.6× 452 0.7× 200 0.6× 70 0.5× 173 1.4× 19 772
Marie‐Josée Le Bris France 18 420 0.6× 551 0.9× 235 0.7× 220 1.6× 63 0.5× 55 986
Françoise Brizard France 14 278 0.4× 343 0.5× 252 0.7× 77 0.6× 87 0.7× 33 680
KS Chang United States 8 811 1.2× 899 1.4× 167 0.5× 69 0.5× 57 0.5× 13 1.2k
CM Rubin United States 15 432 0.6× 847 1.3× 228 0.6× 121 0.9× 42 0.3× 20 1.0k
ID Dube Canada 13 347 0.5× 434 0.7× 225 0.6× 157 1.2× 41 0.3× 25 845
OA Haas Austria 15 407 0.6× 656 1.0× 221 0.6× 66 0.5× 57 0.5× 18 904
Odile Maarek France 13 352 0.5× 645 1.0× 411 1.1× 75 0.6× 231 1.8× 24 1.0k

Countries citing papers authored by A. E. Watmore

Since Specialization
Citations

This map shows the geographic impact of A. E. Watmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Watmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Watmore more than expected).

Fields of papers citing papers by A. E. Watmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. Watmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Watmore. The network helps show where A. E. Watmore may publish in the future.

Co-authorship network of co-authors of A. E. Watmore

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. Watmore. A scholar is included among the top collaborators of A. E. Watmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. Watmore. A. E. Watmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dingli, David, Francis Grand, Jack L. Spurbeck, et al.. (2005). Der(6)t(1;6)(q21–23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia. British Journal of Haematology. 130(2). 229–232. 24 indexed citations
3.
Tan, Soo‐Yong, Susan A. Burchill, Samantha Brownhill, et al.. (2001). Small Round Cell Tumor with Biphenotypic Differentiation and Variant of t(21;22)(q22;q12). Pediatric and Developmental Pathology. 4(4). 391–396. 8 indexed citations
4.
Cuthbert, Gavin, Karen Thompson, A. E. Watmore, et al.. (2000). MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia. 14(11). 1885–1891. 38 indexed citations
5.
Watmore, A. E., et al.. (2000). Acute Monocytic Leukemia with a Novel 10;11 Rearrangement Resolved by Fluorescence In Situ Hybridization. Cancer Genetics and Cytogenetics. 118(1). 20–23. 4 indexed citations
6.
Rowe, David W., Simon Cotterill, F. M. Ross, et al.. (2000). Cytogenetically cryptic AML1-ETO and CBFbeta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia. British Journal of Haematology. 111(4). 1051–1056. 47 indexed citations
7.
Carapeti, Melina, Ricardo C.T. Aguiar, A. E. Watmore, John M. Goldman, & Nicholas C.P. Cross. (1999). Consistent Fusion of MOZ and TIF2 in AML with inv(8)(p11q13). Cancer Genetics and Cytogenetics. 113(1). 70–72. 46 indexed citations
8.
Chase, Andrew, Kim Orchard, A. E. Watmore, et al.. (1998). Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant. British Journal of Haematology. 100(3). 561–563. 29 indexed citations
9.
Sinclair, Elizabeth, A. M. Potter, A. E. Watmore, M Fitchett, & Fiona M. Ross. (1998). Trisomy 15 Associated with Loss of the Y Chromosome in Bone Marrow. Cancer Genetics and Cytogenetics. 105(1). 20–23. 23 indexed citations
10.
Richards, Michael J., et al.. (1998). Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down’s syndrome. Archives of Disease in Childhood Fetal & Neonatal. 79(3). F215–F217. 26 indexed citations
11.
Reilly, John T., John A. Snowden, Ruth Spearing, et al.. (1997). Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases. British Journal of Haematology. 98(1). 96–102. 139 indexed citations
12.
Borrow, Julian, Vincent P. Stanton, J. Michael Andresen, et al.. (1996). The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein. Nature Genetics. 14(1). 33–41. 603 indexed citations breakdown →
13.
Murphy, Philip, et al.. (1995). Acute lymphoblastic transformation of essential thrombocythaemia. British Journal of Haematology. 89(4). 921–922. 6 indexed citations
14.
Reilly, John T., Gill Wilson, David Barnett, A. E. Watmore, & A. M. Potter. (1994). Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis. British Journal of Haematology. 88(3). 575–581. 39 indexed citations
15.
Watmore, A. E., et al.. (1991). Chromosomes in childhood acute lymphoblastic leukaemia: karyotypic patterns in disease subtypes.. Journal of Clinical Pathology. 44(1). 48–51. 11 indexed citations
16.
Yaseen, Nahi Y., A. E. Watmore, A. M. Potter, et al.. (1990). Chromosome studies in eleven colorectal tumors. Cancer Genetics and Cytogenetics. 44(1). 83–97. 25 indexed citations
17.
Griffiths, Helen R., et al.. (1989). Mithramycin therapy for resistant hypercalcaemia in transformed chronic granulocytic leukaemia. Clinical & Laboratory Haematology. 11(2). 156–159. 3 indexed citations
18.
Potter, A. M., et al.. (1988). Methotrexate and bone marrow metaphases. Cancer Genetics and Cytogenetics. 33(2). 213–224. 6 indexed citations
19.
Watmore, A. E., et al.. (1985). Nonendemic Burkitt's lymphoma with complex chromosome abnormalities involving chromosomes 2 and 8. Cancer Genetics and Cytogenetics. 16(4). 283–288. 3 indexed citations
20.
Lilleyman, J S, A. M. Potter, A. E. Watmore, et al.. (1978). Myeloid Karyotype and the Malignant Phase of Chronic Granulocytic Leukaemia. British Journal of Haematology. 39(3). 317–323. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026